Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.

[1]  Christopher G Willett,et al.  Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. , 2012, International journal of radiation oncology, biology, physics.

[2]  David Cella,et al.  Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Niemierko,et al.  Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning. , 2011, International journal of radiation oncology, biology, physics.

[4]  A. Koong,et al.  A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. , 2010, International journal of radiation oncology, biology, physics.

[5]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[6]  P. Price,et al.  Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[7]  T. Schultheiss,et al.  Radiation dose-volume effects in the spinal cord. , 2010, International journal of radiation oncology, biology, physics.

[8]  R. T. Ten Haken,et al.  Radiation-associated liver injury. , 2010, International journal of radiation oncology, biology, physics.

[9]  X Allen Li,et al.  Radiation-associated kidney injury. , 2010, International journal of radiation oncology, biology, physics.

[10]  X Allen Li,et al.  Radiation dose-volume effects in the stomach and small bowel. , 2010, International journal of radiation oncology, biology, physics.

[11]  C. Hurt,et al.  Respiratory movement of upper abdominal organs and its effect on radiotherapy planning in pancreatic cancer. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[12]  M. Choi,et al.  Predictive factors of gastroduodenal toxicity in cirrhotic patients after three-dimensional conformal radiotherapy for hepatocellular carcinoma. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  W. Curran,et al.  Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Lei Xing,et al.  Pancreatic Tumor Motion on a Single Planning 4D-CT Does Not Correlate With Intrafraction Tumor Motion During Treatment , 2009, American journal of clinical oncology.

[15]  T. Briere,et al.  Dose escalation with proton or photon radiation treatment for pancreatic cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Hiroshi Asakura,et al.  Four-dimensional measurement of intrafractional respiratory motion of pancreatic tumors using a 256 multi-slice CT scanner. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  K. Griffith,et al.  Phase I radiation dose-escalation trial of intensity-modulated radiotherapy (IMRT) with concurrent fixed dose-rate gemcitabine (FDR-G) for unresectable pancreatic cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  N. Girard,et al.  Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Suresh Senan,et al.  Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma. , 2008, International journal of radiation oncology, biology, physics.

[20]  T. Desser,et al.  Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. , 2008, International journal of radiation oncology, biology, physics.

[21]  B. Chauffert,et al.  Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  W. Ryder,et al.  Chemoradiotherapy for locally advanced pancreatic cancer: a radiotherapy dose escalation and organ motion study. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[23]  Icru.  Prescribing, recording, and reporting photon beam therapy , 1993 .

[24]  S. Adusumilli,et al.  Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution. , 2007, International journal of radiation oncology, biology, physics.

[25]  D. Goldstein,et al.  Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer , 2007, British Journal of Cancer.

[26]  Edgar Ben-Josef,et al.  Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. , 2007, International journal of radiation oncology, biology, physics.

[27]  Douglas B. Evans,et al.  Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy , 2007, Cancer.

[28]  Masahiko Oguchi,et al.  Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation. , 2007, Anticancer research.

[29]  J. Quivey,et al.  A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. , 2007, International journal of radiation oncology, biology, physics.

[30]  E. Touboul,et al.  Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  N. Spry,et al.  Comparison of non-coplanar and coplanar irradiation techniques to treat cancer of the pancreas. , 2006, Australasian radiology.

[32]  S. Rana,et al.  Does the pancreas move with respiration? , 2006, Journal of gastroenterology and hepatology.

[33]  K. Camphausen,et al.  A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[34]  Quynh-Thu Le,et al.  Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. , 2005, International journal of radiation oncology, biology, physics.

[35]  S. Lipsitz,et al.  A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. , 2005, International journal of radiation oncology, biology, physics.

[36]  H. von der Maase,et al.  Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  S. Song,et al.  A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer. , 2004, International journal of radiation oncology, biology, physics.

[38]  Shinichi Shimizu,et al.  Application of real-time tumor-tracking and gated radiotherapy system for unresectable pancreatic cancer. , 2004, Yonsei medical journal.

[39]  Jay Burmeister,et al.  Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. , 2004, International journal of radiation oncology, biology, physics.

[40]  J. Roeske,et al.  Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. , 2004, International journal of radiation oncology, biology, physics.

[41]  Christopher G Willett,et al.  Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. , 2004, International journal of radiation oncology, biology, physics.

[42]  Albert C Koong,et al.  Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. , 2004, International journal of radiation oncology, biology, physics.

[43]  Daniel Normolle,et al.  Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  F. Chang,et al.  Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. , 2003, International journal of radiation oncology, biology, physics.

[45]  Paul Suetens,et al.  Respiration-induced movement of the upper abdominal organs: a pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  R. Hruban,et al.  Epidemiology and risk factors , 2002 .

[47]  Y. Mataki,et al.  Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. , 2002, International journal of radiation oncology, biology, physics.

[48]  M. Strawderman,et al.  Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  R K Ten Haken,et al.  Partial irradiation of the liver. , 2001, Seminars in radiation oncology.

[50]  T. Conroy,et al.  Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[51]  J. Cassady,et al.  Clinical radiation nephropathy. , 1995, International journal of radiation oncology, biology, physics.

[52]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[53]  L. Dewit,et al.  Radiation injury in the human kidney: a prospective analysis using specific scintigraphic and biochemical endpoints. , 1990, International journal of radiation oncology, biology, physics.

[54]  C. Perez,et al.  Principles and Practice of Radiation Oncology , 1987 .

[55]  P. Engstrom,et al.  Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  T. Pajak,et al.  Multimodality therapy of localized unresectable pancreatic adenocarcinoma , 1984, Cancer.

[57]  H. Mameghan,et al.  Radiation hepatitis following moving strip radiotherapy. , 1983, International journal of radiation oncology, biology, physics.

[58]  J. Barkin,et al.  Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group , 1981, Cancer.

[59]  J. Macfarlane,et al.  Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial. , 1981, Journal of the Canadian Association of Radiologists.

[60]  K. Strubler,et al.  Pancreatic carcinoma treated with high‐dose, small‐volume irradiation , 1978, Cancer.

[61]  F. Mícek.  [Cancer of the pancreas]. , 1965, Bratislavske lekarske listy.

[62]  Powley Jm.  SYMPTOMLESS CANCER IN WOMEN. , 1964 .

[63]  R. Luxton.  Radiation nephritis. A long-term study of 54 patients. , 1961, Lancet.

[64]  S. Guérin,et al.  [Cancer epidemiology in France in 2010, comparison with the USA]. , 2010, Bulletin du cancer.

[65]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[66]  J. Earle,et al.  Evaluation of external-beam radiation therapy plus 5-fluorouracil (5-FU) versus external-beam radiation therapy plus hycanthone (HYC) in confined, unresectable pancreatic cancer. , 1994, International journal of radiation oncology, biology, physics.

[67]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .